167 related articles for article (PubMed ID: 36253320)
41. Rectal cancer radiotherapy.
Vendrely V; Rivin Del Campo E; Modesto A; Jolnerowski M; Meillan N; Chiavassa S; Serre AA; Gérard JP; Créhanges G; Huguet F; Lemanski C; Peiffert D
Cancer Radiother; 2022; 26(1-2):272-278. PubMed ID: 34953708
[TBL] [Abstract][Full Text] [Related]
42. Local Excision Techniques for Rectal Cancer After Neoadjuvant Chemoradiotherapy: What Are We Doing?
Smith FM; Ahad A; Perez RO; Marks J; Bujko K; Heald RJ
Dis Colon Rectum; 2017 Feb; 60(2):228-239. PubMed ID: 28059920
[TBL] [Abstract][Full Text] [Related]
43. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
44. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
45. Neoadjuvant radiotherapy for rectal cancer management.
Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
[No Abstract] [Full Text] [Related]
47. Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
Custers PA; Hupkens BJP; Grotenhuis BA; Kuhlmann KFD; Breukink SO; Beets GL; Melenhorst J;
Colorectal Dis; 2022 Apr; 24(4):401-410. PubMed ID: 35060263
[TBL] [Abstract][Full Text] [Related]
48. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial].
Wang L; Zhao YM; Sun TT; Xu YL; Li SJ; Zhang XY; Cai Y; Li YH; Li ZW; Chen PJ; Peng YF; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):258-265. PubMed ID: 32192305
[No Abstract] [Full Text] [Related]
49. [Rectal Cancer: Organ preservation and neoadjuvant treatment escalation].
Vendrely V; Rullier E
Bull Cancer; 2021 Dec; 108(12):1126-1131. PubMed ID: 34802716
[TBL] [Abstract][Full Text] [Related]
50. Contact X-ray brachytherapy for rectal cancer: Past, present, and future.
Gérard JP; Barbet N; Dejean C; Montagne L; Bénézery K; Coquard R; Doyen J; Durand Labrunie J; Hannoun-Lévi JM
Cancer Radiother; 2021 Dec; 25(8):795-800. PubMed ID: 34052134
[TBL] [Abstract][Full Text] [Related]
51. Local Excision for Early Rectal Cancer.
Cunningham C
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):82-86. PubMed ID: 36137914
[TBL] [Abstract][Full Text] [Related]
52. Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series.
Asoglu O; Bulut A; Aliyev V; Piozzi GN; Guven K; Bakır B; Goksel S
World J Surg Oncol; 2022 Nov; 20(1):358. PubMed ID: 36352416
[TBL] [Abstract][Full Text] [Related]
53. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
Hughes R; Harrison M; Glynne-Jones R
Acta Oncol; 2010 Apr; 49(3):378-81. PubMed ID: 20151936
[TBL] [Abstract][Full Text] [Related]
54. [Neoadjuvant treatment for rectal cancer].
Bachet JB; Benoist S; Mas L; Huguet F
Bull Cancer; 2021 Sep; 108(9):855-867. PubMed ID: 34140155
[TBL] [Abstract][Full Text] [Related]
55. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
56. Organ and Function Preservation in Gastrointestinal Malignancies.
Sur R; Than NW; Taggar A; Sripadam R; Sun Myint A
Clin Oncol (R Coll Radiol); 2023 Aug; 35(8):524-532. PubMed ID: 37357120
[TBL] [Abstract][Full Text] [Related]
57. Local excision after (near) complete response of rectal cancer to neoadjuvant radiation: does it add value?
Jones HJS; Al-Najami I; Baatrup G; Cunningham C
Int J Colorectal Dis; 2021 May; 36(5):1017-1022. PubMed ID: 33409564
[TBL] [Abstract][Full Text] [Related]
58. Response to neoadjuvant therapy for rectal cancer: influence on long-term results.
Biondo S; Navarro M; Marti-Rague J; Arriola E; Pares D; Del Rio C; Cambray M; Novell V
Colorectal Dis; 2005 Sep; 7(5):472-9. PubMed ID: 16108884
[TBL] [Abstract][Full Text] [Related]
59. The use of radiotherapy for patients with low rectal cancer: an overview of the Lyon experience.
Gerard JP
Aust N Z J Surg; 1994 Jul; 64(7):457-63. PubMed ID: 8010914
[TBL] [Abstract][Full Text] [Related]
60. Can less be more? Organ preservation strategies in the management of rectal cancer.
Rouleau-Fournier F; Brown CJ
Curr Oncol; 2019 Nov; 26(Suppl 1):S16-S23. PubMed ID: 31819706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
